Phenaris

Phenaris is a partner of the recently established EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

At Phenaris we constantly challenge the status quo in computational drug design and in silico toxicology.

Using cutting edge technologies we provide data, models, and decision support in all aspects of in silico toxicology. We are currently working on multiple solutions to provide data integration, model development, and decision support.

https://www.phenaris.com/

Latest Tweets

Edelweiss Connect (5 days ago)
See why @wepredic @Biopredic_Intl #HepaRG™ cell model is the best for NAFLD investigations #SaferWorldbyDesign… https://t.co/pzgJbUhY7d
Edelweiss Connect (5 days ago)
Among the few in vitro models proposed to mimic steatosis and its progression, the #HepaRG™ cell model has been a s… https://t.co/XpAVqrKDa2
Edelweiss Connect (5 days ago)
RT @CORDIS_EU: Can we have safe science without #AnimalTesting? A method called induced pluripotent stem cells was the focus of the @in3i…
Edelweiss Connect (6 weeks ago)
This #SaferWorldbyDesign blog post presents a collection of perspectives that elaborate our vision of reliable and… https://t.co/qf47C4UnQD
Edelweiss Connect (2 months ago)
Upcoming #SaferWorldbyDesign webinar October 12 Maieutix, based in Basel, Switzerland, will present a series of c… https://t.co/uHtp1QSNNc

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA